Fmr LLC Sells 566,804 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Fmr LLC cut its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 56.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 438,149 shares of the company’s stock after selling 566,804 shares during the period. Fmr LLC owned approximately 0.89% of Prestige Consumer Healthcare worth $31,591,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Lombard Odier Asset Management USA Corp acquired a new position in Prestige Consumer Healthcare in the second quarter worth about $550,000. Sequoia Financial Advisors LLC increased its holdings in Prestige Consumer Healthcare by 12.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock valued at $708,000 after purchasing an additional 1,120 shares in the last quarter. Pinnacle Associates Ltd. boosted its stake in Prestige Consumer Healthcare by 60.3% in the third quarter. Pinnacle Associates Ltd. now owns 24,630 shares of the company’s stock worth $1,776,000 after purchasing an additional 9,269 shares in the last quarter. Ariel Investments LLC increased its stake in shares of Prestige Consumer Healthcare by 10.7% in the second quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock valued at $195,204,000 after buying an additional 274,212 shares in the last quarter. Finally, Boston Trust Walden Corp bought a new position in shares of Prestige Consumer Healthcare in the third quarter valued at about $41,785,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Down 1.6 %

Shares of NYSE PBH opened at $84.33 on Monday. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $4.17 billion, a PE ratio of 20.52, a price-to-earnings-growth ratio of 2.41 and a beta of 0.49. The firm’s 50-day moving average is $76.78 and its 200-day moving average is $71.91. Prestige Consumer Healthcare Inc. has a 1 year low of $57.95 and a 1 year high of $86.36.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, hitting the consensus estimate of $1.09. The company had revenue of $283.79 million for the quarter, compared to analyst estimates of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The business’s revenue for the quarter was down .9% compared to the same quarter last year. During the same period last year, the business posted $1.07 earnings per share. Equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.44 EPS for the current year.

Wall Street Analysts Forecast Growth

PBH has been the topic of a number of research analyst reports. Jefferies Financial Group reissued a “hold” rating and set a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reissued a “buy” rating and issued a $95.00 price target on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $83.67.

Insider Activity

In other news, EVP Adel Mekhail sold 9,063 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $82.00, for a total value of $743,166.00. Following the sale, the executive vice president now owns 18,365 shares of the company’s stock, valued at $1,505,930. The trade was a 33.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Ronald M. Lombardi sold 10,875 shares of the firm’s stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total transaction of $898,275.00. Following the completion of the transaction, the chief executive officer now directly owns 320,952 shares of the company’s stock, valued at approximately $26,510,635.20. This trade represents a 3.28 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 38,810 shares of company stock worth $3,187,300 over the last three months. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.